Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 96

1.

Association of Total Medication Burden With Intensive and Standard Blood Pressure Control and Clinical Outcomes: A Secondary Analysis of SPRINT.

Derington CG, Gums TH, Bress AP, Herrick JS, Greene TH, Moran AE, Weintraub WS, Kronish IM, Morisky DE, Trinkley KE, Saseen JJ, Reynolds K, Bates JT, Berlowitz DR, Chang TI, Chonchol M, Cushman WC, Foy CG, Herring CT, Katz LA, Krousel-Wood M, Pajewski NM, Tamariz L, King JB; SPRINT Research Group.

Hypertension. 2019 Jul 1:HYPERTENSIONAHA11912907. doi: 10.1161/HYPERTENSIONAHA.119.12907. [Epub ahead of print]

PMID:
31256717
2.

Clinic-Based Strategies to Reach United States Million Hearts 2022 Blood Pressure Control Goals.

Bellows BK, Ruiz-Negrón N, Bibbins-Domingo K, King JB, Pletcher MJ, Moran AE, Fontil V.

Circ Cardiovasc Qual Outcomes. 2019 Jun;12(6):e005624. doi: 10.1161/CIRCOUTCOMES.118.005624. Epub 2019 Jun 5.

PMID:
31163981
3.

Response by Bress et al to Letters Regarding Article, "Potential Cardiovascular Disease Events Prevented With Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline".

Bress AP, Muntner P, Moran AE.

Circulation. 2019 Jun 4;139(23):e1023-e1024. doi: 10.1161/CIRCULATIONAHA.119.040420. Epub 2019 Jun 3. No abstract available.

PMID:
31157999
4.

Prevalence of ambulatory blood pressure phenotypes using the 2017 American College of Cardiology/American Heart Association blood pressure guideline thresholds: data from the Coronary Artery Risk Development in Young Adults study.

Poudel B, Booth JN 3rd, Sakhuja S, Moran AE, Schwartz JE, Lloyd-Jones DM, Lewis CE, Shikany JM, Shimbo D, Muntner P.

J Hypertens. 2019 Jul;37(7):1401-1410. doi: 10.1097/HJH.0000000000002055.

PMID:
31145711
5.

Mobilising society to implement solutions for non-communicable diseases.

Akselrod S, Bloomfield A, Marmot M, Moran AE, Nishtar S, Placella E; NCD expert editorial group.

BMJ. 2019 May 20;365:l360. doi: 10.1136/bmj.l360. No abstract available.

6.

Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association.

Benjamin EJ, Muntner P, Alonso A, Bittencourt MS, Callaway CW, Carson AP, Chamberlain AM, Chang AR, Cheng S, Das SR, Delling FN, Djousse L, Elkind MSV, Ferguson JF, Fornage M, Jordan LC, Khan SS, Kissela BM, Knutson KL, Kwan TW, Lackland DT, Lewis TT, Lichtman JH, Longenecker CT, Loop MS, Lutsey PL, Martin SS, Matsushita K, Moran AE, Mussolino ME, O'Flaherty M, Pandey A, Perak AM, Rosamond WD, Roth GA, Sampson UKA, Satou GM, Schroeder EB, Shah SH, Spartano NL, Stokes A, Tirschwell DL, Tsao CW, Turakhia MP, VanWagner LB, Wilkins JT, Wong SS, Virani SS; American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee.

Circulation. 2019 Mar 5;139(10):e56-e528. doi: 10.1161/CIR.0000000000000659. No abstract available.

PMID:
30700139
7.

Potential Cardiovascular Disease Events Prevented with Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline.

Bress AP, Colantonio LD, Cooper RS, Kramer H, Booth JN 3rd, Odden MC, Bibbins-Domingo K, Shimbo D, Whelton PK, Levitan EB, Howard G, Bellows BK, Kleindorfer D, Safford MM, Muntner P, Moran AE.

Circulation. 2019 Jan 2;139(1):24-36. doi: 10.1161/CIRCULATIONAHA.118.035640.

PMID:
30586736
8.

Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016.

GBD 2016 Lifetime Risk of Stroke Collaborators, Feigin VL, Nguyen G, Cercy K, Johnson CO, Alam T, Parmar PG, Abajobir AA, Abate KH, Abd-Allah F, Abejie AN, Abyu GY, Ademi Z, Agarwal G, Ahmed MB, Akinyemi RO, Al-Raddadi R, Aminde LN, Amlie-Lefond C, Ansari H, Asayesh H, Asgedom SW, Atey TM, Ayele HT, Banach M, Banerjee A, Barac A, Barker-Collo SL, Bärnighausen T, Barregard L, Basu S, Bedi N, Behzadifar M, Béjot Y, Bennett DA, Bensenor IM, Berhe DF, Boneya DJ, Brainin M, Campos-Nonato IR, Caso V, Castañeda-Orjuela CA, Rivas JC, Catalá-López F, Christensen H, Criqui MH, Damasceno A, Dandona L, Dandona R, Davletov K, de Courten B, deVeber G, Dokova K, Edessa D, Endres M, Faraon EJA, Farvid MS, Fischer F, Foreman K, Forouzanfar MH, Gall SL, Gebrehiwot TT, Geleijnse JM, Gillum RF, Giroud M, Goulart AC, Gupta R, Gupta R, Hachinski V, Hamadeh RR, Hankey GJ, Hareri HA, Havmoeller R, Hay SI, Hegazy MI, Hibstu DT, James SL, Jeemon P, John D, Jonas JB, Jóźwiak J, Kalani R, Kandel A, Kasaeian A, Kengne AP, Khader YS, Khan AR, Khang YH, Khubchandani J, Kim D, Kim YJ, Kivimaki M, Kokubo Y, Kolte D, Kopec JA, Kosen S, Kravchenko M, Krishnamurthi R, Kumar GA, Lafranconi A, Lavados PM, Legesse Y, Li Y, Liang X, Lo WD, Lorkowski S, Lotufo PA, Loy CT, Mackay MT, Abd El Razek HM, Mahdavi M, Majeed A, Malekzadeh R, Malta DC, Mamun AA, Mantovani LG, Martins SCO, Mate KK, Mazidi M, Mehata S, Meier T, Melaku YA, Mendoza W, Mensah GA, Meretoja A, Mezgebe HB, Miazgowski T, Miller TR, Ibrahim NM, Mohammed S, Mokdad AH, Moosazadeh M, Moran AE, Musa KI, Negoi RI, Nguyen M, Nguyen QL, Nguyen TH, Tran TT, Nguyen TT, Anggraini Ningrum DN, Norrving B, Noubiap JJ, O’Donnell MJ, Olagunju AT, Onuma OK, Owolabi MO, Parsaeian M, Patton GC, Piradov M, Pletcher MA, Pourmalek F, Prakash V, Qorbani M, Rahman M, Rahman MA, Rai RK, Ranta A, Rawaf D, Rawaf S, Renzaho AM, Robinson SR, Sahathevan R, Sahebkar A, Salomon JA, Santalucia P, Santos IS, Sartorius B, Schutte AE, Sepanlou SG, Shafieesabet A, Shaikh MA, Shamsizadeh M, Sheth KN, Sisay M, Shin MJ, Shiue I, Silva DAS, Sobngwi E, Soljak M, Sorensen RJD, Sposato LA, Stranges S, Suliankatchi RA, Tabarés-Seisdedos R, Tanne D, Nguyen CT, Thakur JS, Thrift AG, Tirschwell DL, Topor-Madry R, Tran BX, Nguyen LT, Truelsen T, Tsilimparis N, Tyrovolas S, Ukwaja KN, Uthman OA, Varakin Y, Vasankari T, Venketasubramanian N, Vlassov VV, Wang W, Werdecker A, Wolfe CDA, Xu G, Yano Y, Yonemoto N, Yu C, Zaidi Z, El Sayed Zaki M, Zhou M, Ziaeian B, Zipkin B, Vos T, Naghavi M, Murray CJL, Roth GA.

N Engl J Med. 2018 Dec 20;379(25):2429-2437. doi: 10.1056/NEJMoa1804492.

9.

Late-Stage Tumor Regression after PD-L1 Blockade Plus a Concurrent OX40 Agonist.

Polesso F, Weinberg AD, Moran AE.

Cancer Immunol Res. 2019 Feb;7(2):269-281. doi: 10.1158/2326-6066.CIR-18-0222. Epub 2018 Dec 18.

PMID:
30563828
10.

Use of a pooled cohort to impute cardiovascular disease risk factors across the adult life course.

Zeki Al Hazzouri A, Vittinghoff E, Zhang Y, Pletcher MJ, Moran AE, Bibbins-Domingo K, Golden SH, Yaffe K.

Int J Epidemiol. 2018 Dec 7. doi: 10.1093/ije/dyy264. [Epub ahead of print]

PMID:
30535320
11.

The 2000-2016 WHF Global Atlas of CVD: Take Two.

Moran AE, Wood DA, Narula J.

Glob Heart. 2018 Sep;13(3):139-141. doi: 10.1016/j.gheart.2018.09.512. No abstract available.

PMID:
30360786
12.

Global Atlas of Cardiovascular Disease 2000-2016: The Path to Prevention and Control.

Thomas H, Diamond J, Vieco A, Chaudhuri S, Shinnar E, Cromer S, Perel P, Mensah GA, Narula J, Johnson CO, Roth GA, Moran AE.

Glob Heart. 2018 Sep;13(3):143-163. doi: 10.1016/j.gheart.2018.09.511. Epub 2018 Oct 6. No abstract available. Erratum in: Glob Heart. 2019 Mar;14(1):97.

PMID:
30301680
13.

Quality Improvement in Cardiovascular Disease Care.

Lee ES, Vedanthan R, Jeemon P, Kamano JH, Kudesia P, Rajan V, Engelgau M, Moran AE.

In: Prabhakaran D, Anand S, Gaziano TA, Mbanya JC, Wu Y, Nugent R, editors. Cardiovascular, Respiratory, and Related Disorders. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 17. Chapter 18.

14.

Ischemic Heart Disease: Cost-Effective Acute Management and Secondary Prevention.

Dugani SB, Moran AE, Bonow RO, Gaziano TA.

In: Prabhakaran D, Anand S, Gaziano TA, Mbanya JC, Wu Y, Nugent R, editors. Cardiovascular, Respiratory, and Related Disorders. 3rd edition. Washington (DC): The International Bank for Reconstruction and Development / The World Bank; 2017 Nov 17. Chapter 8.

15.

Nod2 Deficiency Augments Th17 Responses and Exacerbates Autoimmune Arthritis.

Napier RJ, Lee EJ, Vance EE, Snow PE, Samson KA, Dawson CE, Moran AE, Stenzel P, Davey MP, Sakaguchi S, Rosenzweig HL.

J Immunol. 2018 Oct 1;201(7):1889-1898. doi: 10.4049/jimmunol.1700507. Epub 2018 Aug 27.

PMID:
30150283
16.

Harmonization of Respiratory Data From 9 US Population-Based Cohorts: The NHLBI Pooled Cohorts Study.

Oelsner EC, Balte PP, Cassano PA, Couper D, Enright PL, Folsom AR, Hankinson J, Jacobs DR Jr, Kalhan R, Kaplan R, Kronmal R, Lange L, Loehr LR, London SJ, Navas Acien A, Newman AB, O'Connor GT, Schwartz JE, Smith LJ, Yeh F, Zhang Y, Moran AE, Mwasongwe S, White WB, Yende S, Barr RG.

Am J Epidemiol. 2018 Nov 1;187(11):2265-2278. doi: 10.1093/aje/kwy139.

PMID:
29982273
17.

The Burden of Cardiovascular Diseases Among US States, 1990-2016.

Global Burden of Cardiovascular Diseases Collaboration, Roth GA, Johnson CO, Abate KH, Abd-Allah F, Ahmed M, Alam K, Alam T, Alvis-Guzman N, Ansari H, Ärnlöv J, Atey TM, Awasthi A, Awoke T, Barac A, Bärnighausen T, Bedi N, Bennett D, Bensenor I, Biadgilign S, Castañeda-Orjuela C, Catalá-López F, Davletov K, Dharmaratne S, Ding EL, Dubey M, Faraon EJA, Farid T, Farvid MS, Feigin V, Fernandes J, Frostad J, Gebru A, Geleijnse JM, Gona PN, Griswold M, Hailu GB, Hankey GJ, Hassen HY, Havmoeller R, Hay S, Heckbert SR, Irvine CMS, James SL, Jara D, Kasaeian A, Khan AR, Khera S, Khoja AT, Khubchandani J, Kim D, Kolte D, Lal D, Larsson A, Linn S, Lotufo PA, Magdy Abd El Razek H, Mazidi M, Meier T, Mendoza W, Mensah GA, Meretoja A, Mezgebe HB, Mirrakhimov E, Mohammed S, Moran AE, Nguyen G, Nguyen M, Ong KL, Owolabi M, Pletcher M, Pourmalek F, Purcell CA, Qorbani M, Rahman M, Rai RK, Ram U, Reitsma MB, Renzaho AMN, Rios-Blancas MJ, Safiri S, Salomon JA, Sartorius B, Sepanlou SG, Shaikh MA, Silva D, Stranges S, Tabarés-Seisdedos R, Tadele Atnafu N, Thakur JS, Topor-Madry R, Truelsen T, Tuzcu EM, Tyrovolas S, Ukwaja KN, Vasankari T, Vlassov V, Vollset SE, Wakayo T, Weintraub R, Wolfe C, Workicho A, Xu G, Yadgir S, Yano Y, Yip P, Yonemoto N, Younis M, Yu C, Zaidi Z, Zaki MES, Zipkin B, Afshin A, Gakidou E, Lim SS, Mokdad AH, Naghavi M, Vos T, Murray CJL.

JAMA Cardiol. 2018 May 1;3(5):375-389. doi: 10.1001/jamacardio.2018.0385.

18.

Whom to Treat for High Blood Pressure-Time for a Precision Approach.

Moran AE, Pletcher MJ, Bibbins-Domingo K.

JAMA Intern Med. 2018 Jan 1;178(1):37-38. doi: 10.1001/jamainternmed.2017.7853. No abstract available.

PMID:
29297011
19.

Predictors of response and resistance to checkpoint inhibitors in solid tumors.

Rao SV, Moran AE, Graff JN.

Ann Transl Med. 2017 Dec;5(23):468. doi: 10.21037/atm.2017.09.35. No abstract available.

20.

Secondary Prevention of CVD in LMIC: Care for the Growing Affected Population.

Moran AE, Narula J.

Glob Heart. 2017 Dec;12(4):271-272. doi: 10.1016/j.gheart.2017.10.004. No abstract available.

PMID:
29179888
21.

Nutrition Label Use and Sodium Intake in the U.S.

Zhang D, Li Y, Wang G, Moran AE, Pagán JA.

Am J Prev Med. 2017 Dec;53(6S2):S220-S227. doi: 10.1016/j.amepre.2017.06.007.

22.

Primary Prevention in LMIC: From Population-Based Surveys to Risk Factor Interventions.

Moran AE, Narula J.

Glob Heart. 2017 Sep;12(3):177-178. doi: 10.1016/j.gheart.2017.10.001. No abstract available.

PMID:
29092759
23.

Ischaemic heart disease in the former Soviet Union 1990-2015 according to the Global Burden of Disease 2015 Study.

Murphy A, Johnson CO, Roth GA, Forouzanfar MH, Naghavi M, Ng M, Pogosova N, Vos T, Murray CJL, Moran AE.

Heart. 2018 Jan;104(1):58-66. doi: 10.1136/heartjnl-2016-311142. Epub 2017 Sep 7.

24.

Potential Cardiovascular and Total Mortality Benefits of Air Pollution Control in Urban China.

Huang C, Moran AE, Coxson PG, Yang X, Liu F, Cao J, Chen K, Wang M, He J, Goldman L, Zhao D, Kinney PL, Gu D.

Circulation. 2017 Oct 24;136(17):1575-1584. doi: 10.1161/CIRCULATIONAHA.116.026487. Epub 2017 Sep 7.

25.

Trends in the Prevalence, Awareness, Treatment, and Control of Hypertension Among Young Adults in the United States, 1999 to 2014.

Zhang Y, Moran AE.

Hypertension. 2017 Oct;70(4):736-742. doi: 10.1161/HYPERTENSIONAHA.117.09801. Epub 2017 Aug 28.

26.

Cost-Effectiveness of Intensive versus Standard Blood-Pressure Control.

Bress AP, Bellows BK, King JB, Hess R, Beddhu S, Zhang Z, Berlowitz DR, Conroy MB, Fine L, Oparil S, Morisky DE, Kazis LE, Ruiz-Negrón N, Powell J, Tamariz L, Whittle J, Wright JT Jr, Supiano MA, Cheung AK, Weintraub WS, Moran AE; SPRINT Research Group.

N Engl J Med. 2017 Aug 24;377(8):745-755. doi: 10.1056/NEJMsa1616035.

27.

Updated Cost-effectiveness Analysis of PCSK9 Inhibitors Based on the Results of the FOURIER Trial.

Kazi DS, Penko J, Coxson PG, Moran AE, Ollendorf DA, Tice JA, Bibbins-Domingo K.

JAMA. 2017 Aug 22;318(8):748-750. doi: 10.1001/jama.2017.9924. No abstract available.

28.

Invited Commentary: Quantifying the Added Value of Repeated Measurements.

Moran AE, Liu K.

Am J Epidemiol. 2017 Oct 15;186(8):908-909. doi: 10.1093/aje/kwx146.

PMID:
28633288
29.

Effects of ketamine on the unconditioned and conditioned locomotor activity of preadolescent and adolescent rats: impact of age, sex, and drug dose.

McDougall SA, Moran AE, Baum TJ, Apodaca MG, Real V.

Psychopharmacology (Berl). 2017 Sep;234(18):2683-2696. doi: 10.1007/s00213-017-4660-3. Epub 2017 Jun 7.

30.

Cardiovascular Risk Assessment.

Pletcher MJ, Moran AE.

Med Clin North Am. 2017 Jul;101(4):673-688. doi: 10.1016/j.mcna.2017.03.002. Review.

PMID:
28577619
31.

Global, Regional, and National Burden of Cardiovascular Diseases for 10 Causes, 1990 to 2015.

Roth GA, Johnson C, Abajobir A, Abd-Allah F, Abera SF, Abyu G, Ahmed M, Aksut B, Alam T, Alam K, Alla F, Alvis-Guzman N, Amrock S, Ansari H, Ärnlöv J, Asayesh H, Atey TM, Avila-Burgos L, Awasthi A, Banerjee A, Barac A, Bärnighausen T, Barregard L, Bedi N, Belay Ketema E, Bennett D, Berhe G, Bhutta Z, Bitew S, Carapetis J, Carrero JJ, Malta DC, Castañeda-Orjuela CA, Castillo-Rivas J, Catalá-López F, Choi JY, Christensen H, Cirillo M, Cooper L Jr, Criqui M, Cundiff D, Damasceno A, Dandona L, Dandona R, Davletov K, Dharmaratne S, Dorairaj P, Dubey M, Ehrenkranz R, El Sayed Zaki M, Faraon EJA, Esteghamati A, Farid T, Farvid M, Feigin V, Ding EL, Fowkes G, Gebrehiwot T, Gillum R, Gold A, Gona P, Gupta R, Habtewold TD, Hafezi-Nejad N, Hailu T, Hailu GB, Hankey G, Hassen HY, Abate KH, Havmoeller R, Hay SI, Horino M, Hotez PJ, Jacobsen K, James S, Javanbakht M, Jeemon P, John D, Jonas J, Kalkonde Y, Karimkhani C, Kasaeian A, Khader Y, Khan A, Khang YH, Khera S, Khoja AT, Khubchandani J, Kim D, Kolte D, Kosen S, Krohn KJ, Kumar GA, Kwan GF, Lal DK, Larsson A, Linn S, Lopez A, Lotufo PA, El Razek HMA, Malekzadeh R, Mazidi M, Meier T, Meles KG, Mensah G, Meretoja A, Mezgebe H, Miller T, Mirrakhimov E, Mohammed S, Moran AE, Musa KI, Narula J, Neal B, Ngalesoni F, Nguyen G, Obermeyer CM, Owolabi M, Patton G, Pedro J, Qato D, Qorbani M, Rahimi K, Rai RK, Rawaf S, Ribeiro A, Safiri S, Salomon JA, Santos I, Santric Milicevic M, Sartorius B, Schutte A, Sepanlou S, Shaikh MA, Shin MJ, Shishehbor M, Shore H, Silva DAS, Sobngwi E, Stranges S, Swaminathan S, Tabarés-Seisdedos R, Tadele Atnafu N, Tesfay F, Thakur JS, Thrift A, Topor-Madry R, Truelsen T, Tyrovolas S, Ukwaja KN, Uthman O, Vasankari T, Vlassov V, Vollset SE, Wakayo T, Watkins D, Weintraub R, Werdecker A, Westerman R, Wiysonge CS, Wolfe C, Workicho A, Xu G, Yano Y, Yip P, Yonemoto N, Younis M, Yu C, Vos T, Naghavi M, Murray C.

J Am Coll Cardiol. 2017 Jul 4;70(1):1-25. doi: 10.1016/j.jacc.2017.04.052. Epub 2017 May 17.

32.

Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey).

Bress AP, Kramer H, Khatib R, Beddhu S, Cheung AK, Hess R, Bansal VK, Cao G, Yee J, Moran AE, Durazo-Arvizu R, Muntner P, Cooper RS.

Circulation. 2017 Apr 25;135(17):1617-1628. doi: 10.1161/CIRCULATIONAHA.116.025322. Epub 2017 Feb 13.

33.

Who does not reduce their sodium intake despite being advised to do so? A population segmentation analysis.

Li Y, Berenson J, Moran AE, Pagán JA.

Prev Med. 2017 Jun;99:77-79. doi: 10.1016/j.ypmed.2017.01.017. Epub 2017 Feb 9.

PMID:
28189807
34.

Population Impact & Efficiency of Benefit-Targeted Versus Risk-Targeted Statin Prescribing for Primary Prevention of Cardiovascular Disease.

Pletcher MJ, Pignone M, Jarmul JA, Moran AE, Vittinghoff E, Newman T.

J Am Heart Assoc. 2017 Feb 10;6(2). pii: e004316. doi: 10.1161/JAHA.116.004316.

35.

New country-specific CVD risk charts: recalibrate and refine.

Moran AE.

Lancet Diabetes Endocrinol. 2017 Mar;5(3):155-157. doi: 10.1016/S2213-8587(17)30016-5. Epub 2017 Jan 24. No abstract available.

PMID:
28126461
36.

Prevalence of Masked Hypertension Among US Adults With Nonelevated Clinic Blood Pressure.

Wang YC, Shimbo D, Muntner P, Moran AE, Krakoff LR, Schwartz JE.

Am J Epidemiol. 2017 Feb 1;185(3):194-202. doi: 10.1093/aje/kww237.

37.

Global Burden of Hypertension and Systolic Blood Pressure of at Least 110 to 115 mm Hg, 1990-2015.

Forouzanfar MH, Liu P, Roth GA, Ng M, Biryukov S, Marczak L, Alexander L, Estep K, Hassen Abate K, Akinyemiju TF, Ali R, Alvis-Guzman N, Azzopardi P, Banerjee A, Bärnighausen T, Basu A, Bekele T, Bennett DA, Biadgilign S, Catalá-López F, Feigin VL, Fernandes JC, Fischer F, Gebru AA, Gona P, Gupta R, Hankey GJ, Jonas JB, Judd SE, Khang YH, Khosravi A, Kim YJ, Kimokoti RW, Kokubo Y, Kolte D, Lopez A, Lotufo PA, Malekzadeh R, Melaku YA, Mensah GA, Misganaw A, Mokdad AH, Moran AE, Nawaz H, Neal B, Ngalesoni FN, Ohkubo T, Pourmalek F, Rafay A, Rai RK, Rojas-Rueda D, Sampson UK, Santos IS, Sawhney M, Schutte AE, Sepanlou SG, Shifa GT, Shiue I, Tedla BA, Thrift AG, Tonelli M, Truelsen T, Tsilimparis N, Ukwaja KN, Uthman OA, Vasankari T, Venketasubramanian N, Vlassov VV, Vos T, Westerman R, Yan LL, Yano Y, Yonemoto N, Zaki ME, Murray CJ.

JAMA. 2017 Jan 10;317(2):165-182. doi: 10.1001/jama.2016.19043. Erratum in: JAMA. 2017 Feb 14;317(6):648.

38.

The Global Burden of Disease Study and the Preventable Burden of NCD.

Benziger CP, Roth GA, Moran AE.

Glob Heart. 2016 Dec;11(4):393-397. doi: 10.1016/j.gheart.2016.10.024. Review.

PMID:
27938824
39.

Cost-effectiveness of PCSK9 Inhibitor Therapy-Reply.

Kazi DS, Moran AE, Bibbins-Domingo K.

JAMA. 2016 Nov 22;316(20):2152. doi: 10.1001/jama.2016.16292. No abstract available.

PMID:
27893125
40.

Projected Impact of Mexico's Sugar-Sweetened Beverage Tax Policy on Diabetes and Cardiovascular Disease: A Modeling Study.

Sánchez-Romero LM, Penko J, Coxson PG, Fernández A, Mason A, Moran AE, Ávila-Burgos L, Odden M, Barquera S, Bibbins-Domingo K.

PLoS Med. 2016 Nov 1;13(11):e1002158. doi: 10.1371/journal.pmed.1002158. eCollection 2016 Nov.

41.

Cost-effectiveness of PCSK9 Inhibitor Therapy in Patients With Heterozygous Familial Hypercholesterolemia or Atherosclerotic Cardiovascular Disease.

Kazi DS, Moran AE, Coxson PG, Penko J, Ollendorf DA, Pearson SD, Tice JA, Guzman D, Bibbins-Domingo K.

JAMA. 2016 Aug 16;316(7):743-53. doi: 10.1001/jama.2016.11004.

PMID:
27533159
42.

Immunotherapy Expands and Maintains the Function of High-Affinity Tumor-Infiltrating CD8 T Cells In Situ.

Moran AE, Polesso F, Weinberg AD.

J Immunol. 2016 Sep 15;197(6):2509-21. doi: 10.4049/jimmunol.1502659. Epub 2016 Aug 8.

43.

Still on the Road to Worldwide Hypertension Control.

Moran AE.

Circulation. 2016 Aug 9;134(6):451-4. doi: 10.1161/CIRCULATIONAHA.116.023960. No abstract available.

PMID:
27502909
44.

Quality Improvement for Cardiovascular Disease Care in Low- and Middle-Income Countries: A Systematic Review.

Lee ES, Vedanthan R, Jeemon P, Kamano JH, Kudesia P, Rajan V, Engelgau M, Moran AE.

PLoS One. 2016 Jun 14;11(6):e0157036. doi: 10.1371/journal.pone.0157036. eCollection 2016.

45.

Gait Speed as a Guide for Blood Pressure Targets in Older Adults: A Modeling Study.

Odden MC, Moran AE, Coxson PG, Peralta CA, Goldman L, Bibbins-Domingo K.

J Am Geriatr Soc. 2016 May;64(5):1015-23. doi: 10.1111/jgs.14084.

46.

Comparative Cost-Effectiveness of Conservative or Intensive Blood Pressure Treatment Guidelines in Adults Aged 35-74 Years: The Cardiovascular Disease Policy Model.

Moise N, Huang C, Rodgers A, Kohli-Lynch CN, Tzong KY, Coxson PG, Bibbins-Domingo K, Goldman L, Moran AE.

Hypertension. 2016 Jul;68(1):88-96. doi: 10.1161/HYPERTENSIONAHA.115.06814. Epub 2016 May 15.

47.

Comparative Cost-Effectiveness of Hypertension Treatment in Non-Hispanic Blacks and Whites According to 2014 Guidelines: A Modeling Study.

Vasudeva E, Moise N, Huang C, Mason A, Penko J, Goldman L, Coxson PG, Bibbins-Domingo K, Moran AE.

Am J Hypertens. 2016 Oct;29(10):1195-205. doi: 10.1093/ajh/hpw047. Epub 2016 May 12.

48.

Young Adult Exposure to Cardiovascular Risk Factors and Risk of Events Later in Life: The Framingham Offspring Study.

Pletcher MJ, Vittinghoff E, Thanataveerat A, Bibbins-Domingo K, Moran AE.

PLoS One. 2016 May 3;11(5):e0154288. doi: 10.1371/journal.pone.0154288. eCollection 2016.

49.

Projected Impact of Salt Restriction on Prevention of Cardiovascular Disease in China: A Modeling Study.

Wang M, Moran AE, Liu J, Coxson PG, Penko J, Goldman L, Bibbins-Domingo K, Zhao D.

PLoS One. 2016 Feb 3;11(2):e0146820. doi: 10.1371/journal.pone.0146820. eCollection 2016.

50.

Stroke Prevalence, Mortality and Disability-Adjusted Life Years in Adults Aged 20-64 Years in 1990-2013: Data from the Global Burden of Disease 2013 Study.

Krishnamurthi RV, Moran AE, Feigin VL, Barker-Collo S, Norrving B, Mensah GA, Taylor S, Naghavi M, Forouzanfar MH, Nguyen G, Johnson CO, Vos T, Murray CJ, Roth GA; GBD 2013 Stroke Panel Experts Group.

Neuroepidemiology. 2015;45(3):190-202. doi: 10.1159/000441098. Epub 2015 Oct 28. Erratum in: Neuroepidemiology. 2016;46(3):181.

Supplemental Content

Loading ...
Support Center